Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Chan

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Nature Communications|April 16, 2025
Elevated mitochondrial membrane potential is a therapeutic vulnerability in Dnmt3a-mutant clonal hematopoiesisKira A Young, Mohsen Hosseini, Jayna J Mistry, et al.
Haematologica|March 26, 2026
Extracellular vesicles from aged individuals trigger mitochondrial dysfunction in haematopoietic progenitor cellsIsabelle J Grenier-Pleau, Jasleen Kaur, Christopher J Wells, et al.
Leukemia Research|March 9, 2018
AML refractory to primary induction with Ida-FLAG has a poor clinical outcomeSimon Kavanagh, Emily Heath, Rose Hurren, et al.
Haematologica|July 10, 2025
Real-world validation study of the LSC17 score for risk prediction in patients with newly diagnosed acute myeloid leukemiaTracy Murphy, Boyang Zhang, Tong Zhang, et al.
Research Square|February 26, 2024
Metformin reduces the clonal fitness of <i>Dnmt3a</i> <sup>R878H</sup> hematopoietic stem and progenitor cells by reversing their aberrant metabolic and epigenetic stateMohsen Hosseini, Veronique Voisin, Ali Chegini, et al.
Cell Stem Cell|May 17, 2020
Disrupting Mitochondrial Copper Distribution Inhibits Leukemic Stem Cell Self-RenewalRashim Pal Singh, Danny V Jeyaraju, Veronique Voisin, et al.
Nature|April 16, 2025
Metformin reduces the competitive advantage of Dnmt3a<sup>R878H</sup> HSPCsMohsen Hosseini, Veronique Voisin, Ali Chegini, et al.
Blood Cancer Discovery|January 12, 2022
Multiomic Profiling of Central Nervous System Leukemia Identifies mRNA Translation as a Therapeutic TargetRobert J Vanner, Stephanie M Dobson, Olga I Gan, et al.
Cancer Research|November 11, 2025
Response to Immune Checkpoint Blockade is Enhanced in the Presence of Hematopoietic TET2 InactivationVincent Rondeau, Suraj Bansal, Marco M Buttigieg, et al.
Biorxiv : the Preprint Server for Biology|March 23, 2026
Aberrant oxidative metabolism selects for <i>TET2</i> -deficient hematopoietic stem and progenitor cellsKatia E Niño, Vera Adema, Alyx E Gray, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Nature Communications|April 16, 2025
Elevated mitochondrial membrane potential is a therapeutic vulnerability in Dnmt3a-mutant clonal hematopoiesisKira A Young, Mohsen Hosseini, Jayna J Mistry, et al.
Haematologica|March 26, 2026
Extracellular vesicles from aged individuals trigger mitochondrial dysfunction in haematopoietic progenitor cellsIsabelle J Grenier-Pleau, Jasleen Kaur, Christopher J Wells, et al.
Leukemia Research|March 9, 2018
AML refractory to primary induction with Ida-FLAG has a poor clinical outcomeSimon Kavanagh, Emily Heath, Rose Hurren, et al.
Haematologica|July 10, 2025
Real-world validation study of the LSC17 score for risk prediction in patients with newly diagnosed acute myeloid leukemiaTracy Murphy, Boyang Zhang, Tong Zhang, et al.
Research Square|February 26, 2024
Metformin reduces the clonal fitness of <i>Dnmt3a</i> <sup>R878H</sup> hematopoietic stem and progenitor cells by reversing their aberrant metabolic and epigenetic stateMohsen Hosseini, Veronique Voisin, Ali Chegini, et al.
Cell Stem Cell|May 17, 2020
Disrupting Mitochondrial Copper Distribution Inhibits Leukemic Stem Cell Self-RenewalRashim Pal Singh, Danny V Jeyaraju, Veronique Voisin, et al.
Nature|April 16, 2025
Metformin reduces the competitive advantage of Dnmt3a<sup>R878H</sup> HSPCsMohsen Hosseini, Veronique Voisin, Ali Chegini, et al.
Blood Cancer Discovery|January 12, 2022
Multiomic Profiling of Central Nervous System Leukemia Identifies mRNA Translation as a Therapeutic TargetRobert J Vanner, Stephanie M Dobson, Olga I Gan, et al.
Cancer Research|November 11, 2025
Response to Immune Checkpoint Blockade is Enhanced in the Presence of Hematopoietic TET2 InactivationVincent Rondeau, Suraj Bansal, Marco M Buttigieg, et al.
Biorxiv : the Preprint Server for Biology|March 23, 2026
Aberrant oxidative metabolism selects for <i>TET2</i> -deficient hematopoietic stem and progenitor cellsKatia E Niño, Vera Adema, Alyx E Gray, et al.
Pageof 7